A recent study has brought interesting news for those using diabetes medication for weight loss. It turns out that Mounjaro is more effective than Ozempic in helping overweight and obese adults lose weight.
Both drugs work similarly, mimicking the GLP-1 hormone, but Mounjaro’s additional hormone action seems to give it the upper hand.
While this new study awaits peer review, its findings are consistent with clinical trials and practitioners’ observations. The direct comparison of these drugs, particularly for non-diabetic patients, is a growing area of interest, with more comprehensive results expected in the future.
Notably, this study comes from Truveta, a data firm partnering with several healthcare systems, and not from the drugs’ manufacturers. This independent research uses vast patient data to inform and compare the effectiveness of these medications.
